RISK OF MULTIPLE DRUG INTERACTIONS POTENTIALLY LINKED TO SAFETY IN PATIENTS RECEIVING PANGENOTYPIC DIRECT-ACTING ANTIVIRALS FOR THE TREATMENT OF HEPATITIS C

被引：0
|
作者：
Turnes, Juan [1 ]
Garcia-Herola, Antonio [2 ]
Morillo, Ramon [3 ]
Mendez, Marinela [4 ]
Rueda, Magdalena [4 ]
Hernandez, Candido [5 ]
Sicras-Mainar, Antoni [6 ]
机构：
[1] CHU, Gastroenterol & Hepatol Dept, Pontevedra, Spain
[2] Hosp Marina Baixa de Villajoyosa, Digest Med Dept, Alicante, Spain
[3] AGS Sur Sevilla, Hosp Valme, Hosp Pharm, Seville, Spain
[4] Gilead Sci SL, Med Affairs, Madrid, Spain
[5] Gilead Sci Europe Ltd, Global Med Affairs, London, England
[6] Atrys Hlth, Hlth Econ & Outcomes Res, Barcelona, Spain
来源：
GUT | 2022年 / 71卷
关键词：
D O I：
10.1136/gutjnl-2022-IDDF.125
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
IDDF2022-A
引用
收藏
页码：A97 / A98
页数：2
相关论文
共 50 条
  • [41] Clinical impact of drug interaction in the use of antipsychotics by HCV patients treated with pangenotypic direct-acting antivirals
    Turnes, Juan
    Garcia Herola, Antonio
    Morillo Verdugo, Ramon
    Mendez Pertuz, Marinela
    De Alvaro, Cristina
    Hernandez, Candido
    Sicras-Mainar, Antoni
    JOURNAL OF HEPATOLOGY, 2022, 77 : S268 - S268
  • [42] Prevalence of drug-drug interactions with pangenotypic direct-acting antivirals for hepatitis C and real-world care management in the United States: a retrospective observational study
    Curry, Michael P.
    Flamm, Steven L.
    Milligan, Scott
    Tsai, Naoky
    Wick, Nicole
    Younossi, Zobair
    Afdhal, Nezam H.
    JOURNAL OF MANAGED CARE & SPECIALTY PHARMACY, 2021, 27 (09): : 1239 - 1248
  • [43] The majority of hepatitis C patients treated with direct acting antivirals are at risk for relevant drug-drug interactions
    Smolders, Elise J.
    Berden, Floor A. C.
    de Kanter, Clara T. M. M.
    Kievit, Wietske
    Drenth, Joost P. H.
    Burger, David M.
    UNITED EUROPEAN GASTROENTEROLOGY JOURNAL, 2017, 5 (05) : 648 - 657
  • [44] Direct-Acting Antivirals Treatment Effects for Chronic Hepatitis C Patients with Maintenance Dialysis
    Shih, Ming-Huang
    Wu, Feng-Mei
    Kang, I-Ching
    Chang, Chia-Chu
    Chious, Ping-Fang
    NEPHROLOGY NURSING JOURNAL, 2018, 45 (02) : 204 - 204
  • [45] Treatment of chronic hepatitis C with direct-acting antivirals: The role of resistance
    Jimenez-Perez, Miguel
    Gonzalez-Grande, Rocio
    Espana Contreras, Pilar
    Pinazo Martinez, Isabel
    de la Cruz Lombardo, Jesus
    Olmedo Martin, Raul
    WORLD JOURNAL OF GASTROENTEROLOGY, 2016, 22 (29) : 6573 - 6581
  • [46] Hepatitis B virus reactivation in cancer patients receiving direct-acting antivirals for hepatitis C virus infection
    Pritchard, Haley
    Hwang, Jessica P.
    Angelidakis, Georgios
    Yibirin, Marcel
    Wang, Lan
    Miller, Ethan
    Torres, Harrys A.
    JOURNAL OF VIRAL HEPATITIS, 2021, 28 (05) : 844 - 848
  • [47] The pharmacological interactions between direct-acting antivirals for the treatment of chronic hepatitis c and psychotropic drugs
    Roncero, Carlos
    Luis Villegas, Jose
    Martinez-Rebollar, Maria
    Buti, Maria
    EXPERT REVIEW OF CLINICAL PHARMACOLOGY, 2018, 11 (10) : 999 - 1030
  • [48] New direct-acting antivirals' combination for the treatment of chronic hepatitis C
    Asselah, Tarik
    Marcellin, Patrick
    LIVER INTERNATIONAL, 2011, 31 : 68 - 77
  • [49] Direct-acting antivirals for the treatment of chronic hepatitis C in patients with chronic kidney disease
    Kohli, Anita
    Alshati, Ali
    Georgie, Fawaz
    Manch, Richard
    Gish, Robert G.
    THERAPEUTIC ADVANCES IN GASTROENTEROLOGY, 2016, 9 (06): : 887 - 897
  • [50] EFFICACY AND SAFETY OF DIRECT-ACTING ANTIVIRALS FOR HEPATITIS C TREATMENT IN ADOLESCENTS AND CHILDREN: A COMPREHENSIVE ANALYSIS
    Huang, Peng
    Fu, Zuqiang
    Yue, Ming
    Shao, Tuo
    Cheng, Zhimeng
    Yang, Jiuliang
    Tian, Yanzhang
    Jeyarajan, Andre
    Zhang, Yun
    Lin, Wenyu
    Chung, Raymond T.
    HEPATOLOGY, 2020, 72 : 553A - 554A
12345